中华结核和呼吸杂志
中華結覈和呼吸雜誌
중화결핵화호흡잡지
Chinese Journal of Tuberculosis and Respiratory Diseases
2008年
4期
260-263
,共4页
彭守春%李振华%康健%侯显明%于润江
彭守春%李振華%康健%侯顯明%于潤江
팽수춘%리진화%강건%후현명%우윤강
肺疾病,间质性%支气管肺泡灌洗液%预后
肺疾病,間質性%支氣管肺泡灌洗液%預後
폐질병,간질성%지기관폐포관세액%예후
Lung diseases,Interstitial%Bronchoalveolar lavage fluid%Prognosis
目的 探讨临床指标、肺功能和BALF中细胞类型与特发性肺纤维化(IPF)患者预后的关系.方法 经临床诊断的43例IPF患者进行肺功能和支气管肺泡灌洗检查.采用Kaplan-Meier检验比较组间生存率,采用Cox比例风险回归方法评价各参数的死亡风险度.结果 IPF患者存在限制性通气功能障碍和弥散功能障碍,FVC占预计值%、肺总量占预计值%和DLCO占预计值%分别为(61±18)%、(54±13)%和(48±14)%.在平均随访30.7个月内,IPF患者诊断后的中位生存期为28.5个月.糖皮质激素和(或)细胞毒类药物治疗不能改变IPF患者的预后.单因素Cox比例风险回归分析结果表明,FVC占预计值%、肺总量占预计值%、DLCO占预计值%、中性粒细胞和嗜酸粒细胞比例是影响IPF患者预后的因素,多因素Cox比例风险回归分析结果表明仅DLCO占预计值%和中性粒细胞比例是影响IPF患者预后的主要因素.结论 IPF患者主要为老年男性,存在限制性通气功能障碍和弥散功能障碍.糖皮质激素和(或)细胞毒类药物不能改变IPF患者的预后.DLCO占预计值%和中性粒细胞比例是影响IPF患者预后的主要因素,其中DLCO占预计值%和IPF患者的预后呈负相关,中性粒细胞比例和IPF患者的预后呈正相关.
目的 探討臨床指標、肺功能和BALF中細胞類型與特髮性肺纖維化(IPF)患者預後的關繫.方法 經臨床診斷的43例IPF患者進行肺功能和支氣管肺泡灌洗檢查.採用Kaplan-Meier檢驗比較組間生存率,採用Cox比例風險迴歸方法評價各參數的死亡風險度.結果 IPF患者存在限製性通氣功能障礙和瀰散功能障礙,FVC佔預計值%、肺總量佔預計值%和DLCO佔預計值%分彆為(61±18)%、(54±13)%和(48±14)%.在平均隨訪30.7箇月內,IPF患者診斷後的中位生存期為28.5箇月.糖皮質激素和(或)細胞毒類藥物治療不能改變IPF患者的預後.單因素Cox比例風險迴歸分析結果錶明,FVC佔預計值%、肺總量佔預計值%、DLCO佔預計值%、中性粒細胞和嗜痠粒細胞比例是影響IPF患者預後的因素,多因素Cox比例風險迴歸分析結果錶明僅DLCO佔預計值%和中性粒細胞比例是影響IPF患者預後的主要因素.結論 IPF患者主要為老年男性,存在限製性通氣功能障礙和瀰散功能障礙.糖皮質激素和(或)細胞毒類藥物不能改變IPF患者的預後.DLCO佔預計值%和中性粒細胞比例是影響IPF患者預後的主要因素,其中DLCO佔預計值%和IPF患者的預後呈負相關,中性粒細胞比例和IPF患者的預後呈正相關.
목적 탐토림상지표、폐공능화BALF중세포류형여특발성폐섬유화(IPF)환자예후적관계.방법 경림상진단적43례IPF환자진행폐공능화지기관폐포관세검사.채용Kaplan-Meier검험비교조간생존솔,채용Cox비례풍험회귀방법평개각삼수적사망풍험도.결과 IPF환자존재한제성통기공능장애화미산공능장애,FVC점예계치%、폐총량점예계치%화DLCO점예계치%분별위(61±18)%、(54±13)%화(48±14)%.재평균수방30.7개월내,IPF환자진단후적중위생존기위28.5개월.당피질격소화(혹)세포독류약물치료불능개변IPF환자적예후.단인소Cox비례풍험회귀분석결과표명,FVC점예계치%、폐총량점예계치%、DLCO점예계치%、중성립세포화기산립세포비례시영향IPF환자예후적인소,다인소Cox비례풍험회귀분석결과표명부DLCO점예계치%화중성립세포비례시영향IPF환자예후적주요인소.결론 IPF환자주요위노년남성,존재한제성통기공능장애화미산공능장애.당피질격소화(혹)세포독류약물불능개변IPF환자적예후.DLCO점예계치%화중성립세포비례시영향IPF환자예후적주요인소,기중DLCO점예계치%화IPF환자적예후정부상관,중성립세포비례화IPF환자적예후정정상관.
Objective To determine whether clinical and physiologic variables and bronchoalveolar lavage fluid(BALF)cell profiles affect the survival of patients with idiopathic pulmonary fibrosis (IPF).Methods There were 43 patients with clinically diagnosed IPF in the study.The Kaplan-Meier method and the Log-rank test were used to estimate the survival in the two groups and Cox proportional hazard regression was used to evaluate the Harzard Ratio in the IPF patients.Results The IPF patients presented with restrictive ventilatory disorders[FVC%:(61±18)%,TLC%:(54±13)%]and gas exchange impairment [DLCO%:(48±14)%].The mean follow-up time was 30.7 months,and the median survival of IPF patients was 28.5 months after diagnosis.FVC(Wald=6.71,P<0.01),TLC(Wald=12.37,P<0.01),DLCO(Wald=22.78,P<0.01),neutrophil(Wald=16.26,P<0.01)and eosinophil(Wald=7.73,P<0.01)percentages were prognostic variables in the univariate Cox proportional hazard regression,and only DLCO(HR=0.93,Wald=15.77,P<0.01)and the neutrophil percentage(HR=1.07,Wald=6.83,P<0.01)were prognostic variables for IPF patients in the multivariate Cox proportional hazard regression.Conclusions The IPF patients were predominantly old males and presented with restrictive ventilatory disorders and gas exchange impairment.Glucocorticoids and/or cytotoxic drugs could not improve the prognosis for the IPF patients.DLCO and BALF neutrophil percentage were prognostic variables,and DLCO was negatively correlated with the prognosis while the neutrophil percentage was positively correlated with the prognosis in the IPF patients.